Amphastar Pharmaceuticals (AMPH) Non-cash Items (2013 - 2026)

Amphastar Pharmaceuticals' Non-cash Items history runs 14 years deep, the most recent figure standing at $8.9 million for Q1 2026.

• In Q1 2026, Non-cash Items rose 78.54% year-over-year to $8.9 million; the TTM figure through Mar 2026 stood at $8.9 million (up 78.54% YoY), while the FY2025 annual figure was $4.7 million, down 95.03% from the prior year.
• Non-cash Items was $8.9 million for Q1 2026 at Amphastar Pharmaceuticals, up from $4.7 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $304.8 million in Q2 2023 to a low of $4.7 million in Q4 2025.
• Historically, Non-cash Items has averaged $81.9 million across 5 years, with a median of $33.3 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Non-cash Items jumped 17627.8% in 2022, then slumped 98.31% in 2024.
• A 5-year view of Non-cash Items shows it stood at $5.6 million in 2022, then climbed by 2.44% to $5.7 million in 2023, then surged by 1575.82% to $95.3 million in 2024, then plunged by 95.03% to $4.7 million in 2025, then soared by 87.44% to $8.9 million in 2026.
• The last three Non-cash Items figures came in at $8.9 million (Q1 2026), $4.7 million (Q4 2025), and $33.3 million (Q3 2025), per Business Quant data.